Login
|
Register
News
Media
Insights
Peer Exchange
OncNurse TV
Webinars
Podcasts
Resources
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancers
Supportive Care
Blood Cancers
Prevention
Genetics
Nurse Navigation
Immuno-Oncology
Drug Safety
Skin Cancer/Melanoma
Brain Cancer
Childhood/AYA Cancer
Head and Neck Cancers
Adverse Event Management
Contributors
Conferences
Partners
Advocacy
Associations
Schools of Nursing
Publications
CE
Register now to learn about a new option for relapsed or refractory follicular lymphoma
Immuno-Oncology
Immunotherapy Establishes Its Importance in GU Cancers
BY CAROLINE SEYMOUR
Immunotherapy Is Promising for Cisplatin-Ineligible Metastatic Urothelial Cancer
BY BRITTANY COTE
Immunotherapy in the Age of COVID-19
BY BRIELLE BENYON
Immunotherapy-Related Pneumonitis in Lung Cancer
BY BETH SANDY, MSN, CRNP
Immunotherapy Does Not Increase Death Risk in Patients With COVID-19
BY RACHEL NAROZNIAK, MA
Expert Talks Progress, What's Next in Melanoma Treatment
BY HAYLEY VIRGIL
Immunotherapy/Chemotherapy Regimen Improves Lung Cancer Outcomes, Regardless of Biomarker Status
BY GINA COLUMBUS
Upfront 4-Drug Regimen Is Tolerable in Lung Cancer Treatment
BY BRITTANY COTE
When to Stop Immunotherapy in Metastatic Lung Cancer: Expert Weighs In
BY BRITTANY COTE
Expert Talks Immunotherapy for TNBC Treatment
BY JESSICA HERGERT
<< Prev Page
Next Page >>
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources
Newsroom
Continuing Education
Discussions
Web Exclusives
About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.